Market

Novartis Access to be launched first in Kenya, Ethiopia and Vietnam

Sun Pharma Advanced Research Company (SPARC) announced that the US Food and Drug Administration (US FDA) has issued a Complete…

The inclusion will take effect from October 19 this year

The website is compliant with the guidelines issued by the Department of Administrative Reforms and Public Grievances

BioMarin will allow the Indian drug maker to market a generic version of Kuvan 100mg tablets in the US at a later stage

All current workmen at the Thane plant shall be transferred to the buyer so as to facilitate manufacturing operations

To transfer erstwhile Ranbaxy’s Solus and Solus Care divisions, along with employees to Strides

Nine therapies have outgrown the IPM growth

Discussions were held on HR policies and creation of sustainable work environment

Dr Vatsal Shah has been associated with SIRO Clinpharm since the last three years. He recently took charge as the Chief Operating…

The country has achieved under-five mortality rate decline at an accelerated pace compared to the global rate of decline and India…

Fermenta Biotech and Vitamin Angels are determined to solve the fundamental problem of undernutrition, a widespread challenge,…

Significantly expands NRM capability through two opiates manufacturing facilities in Australia

From April 2016, the trivalent polio vaccine that is currently administered will be replaced by the bivalent variety to reduce…

To develop and commercialise pioneering neuroscience treatments

Valeant said that it would make an upfront payment of $100 million to AstraZeneca

The Rs 850 crore company expects to see organic growth of 15-20 per cent

The think tank likely to be set up within the next two months

Strengthening/ up-gradation of the system will be spread over a period of three years, both at the central and the state levels at…

Novartis will make an initial payment of $300 million to GSK for the acquisition of the compound